ACADIA Pharmaceuticals Inc. (ACAD) has a market capitalization of $3.75B and trades at $22.02. The 52-week range is 13.4-28.35.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 9.5, Earnings Per Share (EPS) of $2.32, annual revenue of $1.07B.
The stock has a beta of 0.83, operates in the Healthcare sector.
